Doç.Dr. Gamze GÜNEY ESKİLER

Doç.Dr.

Gamze GÜNEY ESKİLER

Birim

Tıp Fakültesi

Temel Tıp Bilimleri Bölümü

Google Orc Scopus WOS

İletişim

gamzeguney@sakarya.edu.tr

H-indeks (WoS)

Atıf (WoS)

625

H-indeks (Scopus)

Atıf (Scopus)

H-indeks (Google Scholar)

Atıf (Google Scholar)

ANAHTAR KELİMELER

Apoptosis (12)

Photodynamic therapy (7)

apoptosis (6)

Breast cancer (6)

Triple negative breast cancer (4)

Drug delivery system (3)

ZIF-8 (3)

5-Aminolevulinic acid (2)

ATR (2)

Cabazitaxel (2)

Canine mammary gland tumor (2)

DNA damage response (2)

Drug delivery (2)

Gallic acid (2)

Gemcitabine (2)

Talazoparib (2)

triple-negative breast cancer (2)

Triple-negative breast cancer (2)

3-dioxygenase (IDO) (1)

5-ALA (1)

5-aminolaevulinic acid (1)

5-Aminolevulic acid (5-ALA) (1)

5-aminolevulinic acid (1)

5-Fluorouracil (1)

5-FU (1)

5-Sulfosalicylic acid (1)

6 inhibitors (1)

abemaciclib (1)

Abemaciclib (1)

AKT (1)

antibacterial efficacy (1)

antibacterial properties (1)

Antibiofilm activity (1)

anti-freezing (1)

atypical cell death (1)

Au (1)

Automated experiment (1)

B activity (1)

bee venom (1)

Bioactivity (1)

Boswellic acid (1)

Box-Behnken Design (1)

breast cancer (1)

c.1103A > G (1)

cabazitaxel (1)

caffeic acid (1)

caffeic acid (CA) (1)

cancer (1)

Cancer Therapy (1)

canine mammary gland tumour (1)

Canine mammary tumors (1)

Carcinoma (1)

Carcinosarcoma (1)

Castration resistant metastatic prostate cancer (1)

CDK4 (1)

cell cycle (1)

Cell cycle (1)

cells (1)

characterization (1)

CHEK2 gene (1)

Chitosan hydrogels (1)

Cisplatin (1)

Coelomic fluid (1)

Colorectal cancer (1)

Combination therapy (1)

Combined therapy (1)

complete response (1)

Confocal Microscopy (1)

contrast media (1)

contrast-induced nephropathy (1)

Curcumin (1)

DFT (1)

Docking (1)

dopamine transporter (1)

Dosage control (1)

Dosimetry (1)

drug delivery systems (1)

Drug Delivery Systems (1)

drug release (1)

Drug resistance (1)

Early-onset breast cancer (1)

Eisenia foetida (1)

Embedded systems (1)

endodontic disinfection (1)

Epacadostat (1)

epithelial-mesenchymal transition (1)

Exosomes (1)

Fatty acid profile (1)

Feline mammary gland tumor (1)

Fluorescent (1)

Gastric ulcer (1)

gene expression (1)

Glucose oxidase (1)

hepatitis B (1)

hepatitis B vaccine response (1)

Hepatocellular carcinoma (1)

histone deacetylase inhibitor (1)

honey bee (1)

hydrogel (1)

hypochlorous acid (1)

Inflammation (1)

indoleamine 2 (1)

indoleamine 2,3-dioxygenase (1)

indoleamine 2,3-dioxygenase inhibitors (1)

indoximod (1)

inflammation (1)

inhibitors (1)

irrigation solutions (1)

kidney injury (1)

Lauric acid (1)

Lenalidomide-like novel drug derivative (1)

Light-emitting diodes (LEDs) (1)

Lipid hydrolysis (1)

Liver metastasis (1)

MCF-7 cells (1)

MCF-7 cytotoxicity (1)

Meclofenamic acid (MA) (1)

metabolic dysfunction-associated steatotic liver disease (1)

Metastatic castration-resistant prostate cancer (1)

methamphetamine (1)

MIL-100 (1)

MIL-100 (Fe) (1)

microRNA (1)

MiR-135b (1)

MiR-99b (1)

miRNA (1)

MiRNA (1)

MMPs (1)

mTOR signaling (1)

Multiple real samples (1)

Nano-antibiotic (1)

NF-&#954 (1)

Non-thermal processing (1)

Oxidative damage (1)

Oxidative stability (1)

Peritonitis carcinomatosis (1)

Phosphatidylinositol 3-kinase (PI3K) (1)

PI3K (1)

Poly (ADP -ribose) polymerase (PARP) (1)

pro-inflammatory cytokines (1)

prostate cancer (1)

Prostate Cancer (1)

psychic experiences (1)

Quercetin (1)

radiotherapy (1)

reactive oxygen species (1)

Receptor tyrosine kinases (1)

Resistance (1)

rutaecarpine (1)

self-healing (1)

silver nanoparticles (1)

Silver nanoparticles (1)

SLNs (1)

Small cell lung carcinoma (SCLC) (1)

snail (1)

sodium butyrate (1)

Solid lipid nanoparticles (1)

solid lipid nanoparticles (SLNs). (1)

subtype (1)

Surgical treatment (1)

Synergism (1)

tannic acid (1)

Taxanes (1)

TEM (1)

Thermal processing (1)

Thiazolidine-4-one (1)

Thyroid cancer (1)

TIMPs (1)

toll-like receptor 4 (1)

Topotecan (TPT) (1)

triple negative breast cancer (1)

triple negative breast cancer (TNBC) (1)

tumor necrosis factor-alpha (1)

Vanillic acid (1)

Variant of uncertain significance (1)

vesicular monoamine transporter (1)

Akademik Görevler

DOÇENT

2020

SAKARYA ÜNİVERSİTESİ

TIP FAKÜLTESİ

TEMEL TIP BİLİMLERİ BÖLÜMÜ

DOKTOR ÖĞRETİM ÜYESİ

2019 – 2020

SAKARYA ÜNİVERSİTESİ

TIP FAKÜLTESİ

TEMEL TIP BİLİMLERİ BÖLÜMÜ

ARAŞTIRMA GÖREVLİSİ

2017 – 2019

SAKARYA ÜNİVERSİTESİ

TIP FAKÜLTESİ

TEMEL TIP BİLİMLERİ BÖLÜMÜ

ARAŞTIRMA GÖREVLİSİ

2013 – 2017

ULUDAĞ ÜNİVERSİTESİ

SAĞLIK BİLİMLERİ ENSTİTÜSÜ

TIBBİ BİYOLOJİ (DR)

Öğrenim Bilgisi

Doktora

2013 – 2017

ULUDAĞ ÜNİVERSİTESİ

SAĞLIK BİLİMLERİ ENSTİTÜSÜ/TIBBİ BİYOLOJİ (DR)/

Tez adı: Triple negatif meme kanseri tedavisinde parp inhibitörü yüklü katı lipid nanopartiküllerin ilaç direnç mekanizmalarının aşılmasındaki rollerinin araştırılması

Yüksek Lisans

2008 – 2011

ANADOLU ÜNİVERSİTESİ

FEN BİLİMLERİ ENSTİTÜSÜ/BİYOTEKNOLOJİ (YL) (TEZLİ)/

Tez adı: Askorbik asit yüklü katı lipid nanopartiküllerin kanser hücreleri üzerindeki apoptotik etkileri

Lisans

2004 – 2008

ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ

FEN-EDEBİYAT FAKÜLTESİ/BİYOLOJİ BÖLÜMÜ/BİYOLOJİ PR. (İÖ)/

BM SÜRDÜRÜLEBİLİR KALKINMA AMAÇLARI

Sürdürülebilir Kalkınma Amaçları yoksulluğun son erdirilmesi, çevrenin korunması, iklim krizine karşı önlem alınması, refahın adil paylaşımı ve barışı hedefliyor.